SCHEMBL28598650

SCHEMBL28598650

C=C(C)COC(=O)C1CCNCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 1/20 0.41
GABRD O14764 1/20 0.41
GABRA1 P14867 1/20 0.41
TSHR P16473 1/20 0.41
GABRB1 P18505 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41
GABRA5 P31644 1/20 0.41
GABRA3 P34903 1/20 0.41
GABRA2 P47869 1/20 0.41
GABRB2 P47870 1/20 0.41
GABRA4 P48169 1/20 0.41
GABRE P78334 1/20 0.41
PMP22 Q01453 1/20 0.41
GABRA6 Q16445 1/20 0.41
GABRG1 Q8N1C3 1/20 0.41
GABRG3 Q99928 1/20 0.41
GABRQ Q9UN88 1/20 0.41
NPC1 O15118 1/20 0.35
GNAI3 P08754 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10325880 0.87 MAPT (0.41) NPC1ALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL25845608 0.85 GABRP (0.43) GABRPGABRDGABRA1TSHRGABRB1
SCHEMBL6351424 0.83 ALDH1A1 (0.44) TSHRALDH1A1SMN1; SMN2ATMCASP3
SCHEMBL6359904 0.81 ALDH1A1 (0.46) TSHRALDH1A1SMN1; SMN2MAPTHPGD
SCHEMBL18625010 0.79 GABRA5 (0.50) GABRPGABRDGABRA1TSHRGABRB1
SCHEMBL670170 0.78 GABRP (0.43) GABRPGABRDGABRA1TSHRGABRB1
SCHEMBL13601550 0.77 KDM4E (0.44) GABRPGABRDGABRA1TSHRGABRB1
Ethyl Isonipecotate SCHEMBL27886 0.77 MAPT (0.51) GABRPGABRDGABRA1TSHRGABRB1
Ethyl Isonipecotate SCHEMBL6439825 0.77 MAPT (0.51) GABRPGABRDGABRA1TSHRGABRB1
SCHEMBL11559812 0.76 TSHR (0.42) GABRPGABRDGABRA1TSHRGABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113227103-A Trisubstituted heteroaryl derivatives as SRC homologous-2 phosphatase inhibitors 尼坎医疗公司 2021-08-06 CN disclosed